Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science
This grant funds select academic medical centers to develop innovative programs and resources that address key challenges in clinical and translational science, accelerating the move from research to improved patient care.
Funder: National Institutes of Health
Due Dates (Anticipated): January 2027 (Full application deadline, projected)
Funding Amounts: Award size not specified; typical NIH multi-center program awards are multi-year and substantial. No cost sharing required.
Summary: Supports CTSA Program Hubs in developing and demonstrating unique capabilities or resources to address critical gaps in clinical and translational science.
Key Information: Limited to current CTSA UM1 awardees (PAR-24-272 or later).
Description
This funding opportunity supports High Impact Specialized Innovation Programs (SIPs) at Clinical and Translational Science Award (CTSA) Program Hubs. The goal is to accelerate the translation of scientific discoveries into improved treatments, diagnostics, and health interventions by enabling hubs to develop and demonstrate unique capabilities, research platforms, or resources. These programs are intended to address critical gaps or overcome roadblocks in clinical and translational science, leveraging the national CTSA network's infrastructure, expertise, and collaborative environment. Only organizations with an active CTSA UM1 award (PAR-24-272 or subsequent) are eligible to apply. This is a limited competition, forecasted opportunity.
